Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    CARDIOMYOPATHY, DILATED, 2A
Show Display Options
Rank Status Study
1 Completed Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
Conditions: Diabetes Mellitus, Type 2;   Cardiomyopathy, Dilated
Interventions: Drug: Acipimox;   Drug: Cellulosum Mycrocryst
2 Unknown  Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
Conditions: Heart Failure;   Dilated Cardiomyopathy
Intervention: Drug: clenbuterol
3 Completed
Has Results
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Conditions: Heart Failure, Congestive;   Dilated Cardiomyopathy
Interventions: Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study);   Procedure: Placebo Infusion;   Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)
4 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration

Indicates status has not been verified in more than two years